MaxCyte, Inc. (MXCT.L) LSE

147.69

-12.3077(-7.69%)

Updated at June 25 06:40PM

Currency In GBp

MaxCyte, Inc.

Address

9713 Key West Avenue

Rockville, MD 20850

United States of America

Phone

301 944 1700

Sector

Healthcare

Industry

Medical - Devices

Employees

114

First IPO Date

March 29, 2016

Key Executives

NameTitlePayYear Born
Mr. Maher MasoudPresident, Chief Executive Officer & Executive Director744,1511976
Mr. Ronald Evan Holtz CPA, Ph.D.Executive Vice President of Administration488,1201958
Mr. Ali SoleymannezhadChief Commercial Officer496,2491981
Mr. Douglas J. Swirsky CFA, CPAChief Financial Officer526,5841969
Mr. Douglas Arthur DoerflerFounder1.76M1956
Mr. Jay GelfmanSenior Vice President of Operations0N/A
Ms. Jill MayerSenior Vice President of Human Resources0N/A
Mr. Jack HorganVice President of Corporate Development0N/A
Mr. David SandovalSenior Vice President, General Counsel & Corporate Secretary01978
Ms. Ana-Paula Martins FernandesSenior Vice President of Global Sales0N/A

Description

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.